Kun Pang

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

Zhenduo Shi, Lin Hao, Xiaoxiao Han et al. · Molecular Cancer · 2022 · 120 citations · Full text

The bond properties between UHPC and stone under different interface treatment methods

Zhongya Zhang, Kun Pang, Lihao Xu et al. · Construction and Building Materials · 2022 · 97 citations

Materials Science, Materials Engineering, Engineering +5

<scp>EZH</scp> 2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis

Yu Zhao, Liya Ding, Dejie Wang et al. · The EMBO Journal · 2019 · 75 citations

Tumor Biology, Gain‐of‐function P53 Mutants, Medicine +9

Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota

Suxian Lin, Tao Zhang, Lingxiao Zhu et al. · Journal of genetics and genomics/Journal of Genetics and Genomics · 2021 · 50 citations

Uric Acid-lowering Treatment, Probiotic, Urology +12

Role of NRP1 in Bladder Cancer Pathogenesis and Progression

Yang Dong, Weiming Ma, Zhenduo Shi et al. · Frontiers in Oncology · 2021 · 45 citations · Full text